โรควิตกกังวลไปทั่ว
เชิงอรรถและอ้างอิง

↑  บัญชีจำแนกโรคระหว่างประเทศฉบับประเทศไทย ICD-10-TM
1 2 3 4  Association, American Psychiatric (2013). Diagnostic and statistical manual of mental disorders : DSM-5 (5th ed.). Washington, D.C.: American Psychiatric Association. p. 222. ISBN 978-0-89042-554-1.
1 2  
"What Is Generalized Anxiety Disorder?". National Institute of Mental Health. สืบค้นเมื่อ 28 May 2008.
↑  
Torpy, Janet M.; Burke, AE; Golub, RM (2011). "Generalized Anxiety Disorder". JAMA. 305 (5): 522. doi:10.1001/jama.305.5.522. PMID 21285432.
1 2 International Classification of Diseases ICD-10
Also diagnositic details in Barton, Samantha; Karner, Charlotta; Salih, Fatima; Baldwin, David S; Edwards, Steven J (August 2014). "Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review" (PDF). Health Technology Assessment. 18 (50). Appendix 1, pp. 43-48. doi:10.3310/hta18500. ISSN 1366-5278.{{cite journal}}:  CS1 maint: uses authors parameter (ลิงก์)
1 2  
"The Numbers Count". National Institute of Mental Health. สืบค้นเมื่อ 28 May 2007.
↑  
Lieb, Roselind; Becker, Eni; Altamura, Carlo (2005). "The epidemiology of generalized anxiety disorder in Europe". European Neuropsychopharmacology. 15 (4): 445–52. doi:10.1016/j.euroneuro.2005.04.010. PMID 15951160.
↑  "In The Clinic: Generalized Anxiety Disorder". Annals Of Internal Medicine. 159 (11). 2013.
↑  Rickels, K; Schweizer, E (1990). "The clinical course and long-term management of generalized anxiety disorder". Journal of Clinical Psychopharmacology. 10 (3 Suppl): 101S–110S. doi:10.1097/00004714-199006001-00017. PMID 1973934.
↑  Spitzer, Robert L.; Kroenke, K; Williams, JB; Löwe, B (2006). "A Brief Measure for Assessing Generalized Anxiety Disorder". Archives of Internal Medicine. 166 (10): 1092–7. doi:10.1001/archinte.166.10.1092. PMID 16717171.
↑  Ballenger, JC; Davidson, JR; Lecrubier, Y; Nutt, DJ; Borkovec, TD; Rickels, K; Stein, DJ; Wittchen, HU (2001). "Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety". The Journal of Clinical Psychiatry. 62 Suppl 11: 53–8. PMID 11414552.
↑  Hettema, J. M.; Neale, MC; Kendler, KS (2001). "A Review and Meta-Analysis of the Genetic Epidemiology of Anxiety Disorders". American Journal of Psychiatry. 158 (10): 1568–78. doi:10.1176/appi.ajp.158.10.1568. PMID 11578982.
↑  Donner, Jonas; Pirkola, Sami; Silander, Kaisa; Kananen, Laura; Terwilliger, Joseph D.; Lönnqvist, Jouko; Peltonen, Leena; Hovatta, Iiris (2008). "An Association Analysis of Murine Anxiety Genes in Humans Implicates Novel Candidate Genes for Anxiety Disorders". Biological Psychiatry. 64 (8): 672–80. doi:10.1016/j.biopsych.2008.06.002. PMC 2682432. PMID 18639233.
↑  
Galanter, Marc (1 July 2008). The American Psychiatric Publishing Textbook of Substance Abuse Treatment (American Psychiatric Press Textbook of Substance Abuse Treatment) (4 ed.). American Psychiatric Publishing, Inc. p. 197. ISBN 978-1-58562-276-4.
↑  
Ashton, Heather (2005). "The diagnosis and management of benzodiazepine dependence". Current Opinion in Psychiatry. 18 (3): 249–55. doi:10.1097/01.yco.0000165594.60434.84. PMID 16639148.
↑  Lindsay, S.J.E.; Powell, Graham E., บ.ก. (28 July 1998). The Handbook of Clinical Adult Psychology (2nd ed.). Routledge. p. 173. ISBN 978-0-415-07215-1.
↑  Cargiulo, T. (2007). "Understanding the health impact of alcohol dependence". American Journal of Health-System Pharmacy. 64 (5 Supplement 3): S5-11. doi:10.2146/ajhp060647. PMID 17322182.
↑  Wetterling, T; Junghanns, K (2000). "Psychopathology of alcoholics during withdrawal and early abstinence". European Psychiatry. 15 (8): 483–8. doi:10.1016/S0924-9338(00)00519-8. PMID 11175926.
1 2  Cohen, SI (1995). "Alcohol and benzodiazepines generate anxiety, panic and phobias". Journal of the Royal Society of Medicine. 88 (2): 73–7. PMC 1295099. PMID 7769598.
↑  Morissette, Sandra Baker; Tull, Matthew T.; Gulliver, Suzy Bird; Kamholz, Barbara Wolfsdorf; Zimering, Rose T. (2007). "Anxiety, anxiety disorders, tobacco use, and nicotine: A critical review of interrelationships". Psychological Bulletin. 133 (2): 245–72. doi:10.1037/0033-2909.133.2.245. PMID 17338599.
↑  Bruce, MS; Lader, M; Lader (2009). "Caffeine abstention in the management of anxiety disorders". Psychological Medicine. 19 (1): 211–4. doi:10.1017/S003329170001117X. PMID 2727208.{{cite journal}}:  CS1 maint: multiple names: authors list (ลิงก์)
1 2 3 4  Etkin, Amit; Prater, Katherine E.; Schatzberg, Alan F.; Menon, Vinod; Greicius, Michael D. (2009). "Disrupted Amygdalar Subregion Functional Connectivity and Evidence of a Compensatory Network in Generalized Anxiety Disorder". Archives of General Psychiatry. 66 (12): 1361–72. doi:10.1001/archgenpsychiatry.2009.104. PMID 19996041.
↑  Möller, Hans-Jürgen; Bandelow, Borwin; Bauer, Michael; Hampel, Harald; Herpertz, Sabine C.; Soyka, Michael; Barnikol, Utako B.; Lista, Simone; Severus, Emanuel; Maier, Wolfgang (26 August 2014). "DSM-5 reviewed from different angles: goal attainment, rationality, use of evidence, consequences—part 2: bipolar disorders, schizophrenia spectrum disorders, anxiety disorders, obsessive-compulsive disorders, trauma- and stressor-related disorders, personality disorders, substance-related and addictive disorders, neurocognitive disorders". European Archives of Psychiatry and Clinical Neuroscience. 265: 87–106. doi:10.1007/s00406-014-0521-9.
1 2  Kessler, Ronald C.; Keller, Martin B.; Wittchen, Hans-Ulrich (1 March 2001). "The Epidemiology of Generalized Anxiety Disorder". Psychiatric Clinics of North America. doi:10.1016/S0193-953X(05)70204-5.
1 2 3  Craighead, W. Edward (2013). Psychopathology: History, Diagnosis, and Empirical Foundations. John Wiley & Sons, Inc.
↑  Breslau, Naomi; Davis, Glenn C. (July 1985). "DSM-III generalized anxiety disorder: An empirical investigation of more stringent criteria". Psychiatry Research. doi:10.1016/0165-1781(85)90080-0.
↑  Wittchen, Hans-Ulrich; Kessler, Ronald C.; Zhao, Shanyang; Abelson, Jamie (March–April 1995). "Reliability and clinical validity of UM-CIDI DSM-III-R generalized anxiety disorder". Journal of Psychiatric Research. doi:10.1016/0022-3956(94)00044-R.{{cite journal}}:  CS1 maint: date format (ลิงก์)
↑  Dinsmoor, Robert Scott; Odle, Teresa G. (2015). "Generalized Anxiety Disorder". The Gale Encyclopedia of Medicine. 4 (5): 2149–2150. {{cite journal}}: |access-date= ต้องการ |url= (help)
↑  Bruce, M. S.; Lader, M. (2009). "Caffeine abstention in the management of anxiety disorders". Psychological Medicine. 19 (1): 211–4. doi:10.1017/S003329170001117X. PMID 2727208.
↑  Morissette, SB; Tull, MT; Gulliver, SB; Kamholz, BW; Zimering, RT (March 2007). "Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships". Psychological Bulletin. 133 (2): 245–72. doi:10.1037/0033-2909.133.2.245. PMID 17338599.
↑  Gould, Robert A.; Otto, Michael W.; Pollack, Mark H.; Yap, Liang (1997). "Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis". Behavior Therapy. 28 (2): 285–305. doi:10.1016/S0005-7894(97)80048-2.
↑  Bandelow, Borwin; Sher, Leo; Bunevicius, Robertas; Hollander, Eric; Kasper, Siegfried; Zohar, Joseph; Möller, Hans-Jürgen (June 2012). "Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care" (PDF). International Journal of Psychiatry in Clinical Practice. 16 (2): 77–84. doi:10.3109/13651501.2012.667114. PMID 22540422. S2CID 16253034. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 3 April 2018. สืบค้นเมื่อ 24 November 2015.
1 2  Behar, Evelyn; Dimarco, Ilyse Dobrow; Hekler, Eric B.; Mohlman, Jan; Staples, Alison M. (2009). "Current theoretical models of generalized anxiety disorder (GAD) : Conceptual review and treatment implications". Journal of Anxiety Disorders. 23 (8): 1011–23. doi:10.1016/j.janxdis.2009.07.006. PMID 19700258.
↑  Ruiz, F. J. (2010). "A review of Acceptance and Commitment Therapy (ACT) empirical evidence: Correlational, experimental psychopathology, component and outcome studies". International Journal of Psychology and Psychological Therapy. 10 (1): 125–62.
1 2 3 4 5 6  Hoyer, Jürgen; van der Heiden, Colin; Portman, Michael E. (February 2011). "Psychotherapy for Generalized Anxiety Disorder". Psychiatric Annals. 41 (2): 87–94. doi:10.3928/00485713-20110203-07.
↑  "A Guide to Understanding Cognitive and Behavioural Psychotherapies". British Association for Behavioural and Cognitive Psychotherapies. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 5 May 2007. สืบค้นเมื่อ 29 May 2007.
1 2 3  "Generalized anxiety disorder". Mayo Clinic. สืบค้นเมื่อ 29 May 2007.
↑  Barlow, DH (2007). Clincical Handbook of Psychological Disorders (4th ed.).[ต้องการเลขหน้า]
↑  Roemer, Lizabeth; Orsillo, Susan M. (2006). "Expanding Our Conceptualization of and Treatment for Generalized Anxiety Disorder: Integrating Mindfulness/Acceptance-Based Approaches with Existing Cognitive-Behavioral Models". Clinical Psychology: Science and Practice. 9: 54–68. doi:10.1093/clipsy.9.1.54.
↑  Smout, M (2012). "Acceptance and commitment therapy - pathways for general practitioners". Australian family physician. 41 (9): 672–6. PMID 22962641.
1 2  Baldwin, David S.; Allgulander, Christer; Bandelow, Borwin; Ferre, Francisco; Pallanti, Stefano (October 2012). "An international survey of reported prescribing practice in the treatment of patients with generalised anxiety disorder". The World Journal of Biological Psychiatry. 13 (7): 510–516. doi:10.3109/15622975.2011.624548. ISSN 1814-1412. PMID 22059936. S2CID 35359537.
↑  Bech P, Lönn SL, Overø KF (2010). "Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder". Journal of Clinical Psychiatry. 71 (2): 121–9. doi:10.4088/JCP.08m04749blu. PMID 19961809.
↑  Wagstaff, Antona J.; Cheer, Susan M.; Matheson, Anna J.; Ormrod, Douglas; Goa, Karen L. (2002-01-01). "Paroxetine: an update of its use in psychiatric disorders in adults". Drugs. 62 (4): 655–703. doi:10.2165/00003495-200262040-00010. ISSN 0012-6667. PMID 11893234. S2CID 195692589.
↑  "Antidepressant Medications for Children and Adolescents: Information for Parents and Caregivers". NIMH. National Institute of Mental Health. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 1 March 2010. สืบค้นเมื่อ 1 September 2015.
↑  Barlow, DH; Durand, VM (2009). Abnormal Psychology: An Integrative Approach (5th ed.). Belmont: Wadsworth Cengage Learning. [ต้องการเลขหน้า]
↑  Durham, Rob C. (2007). "Treatment of generalized anxiety disorder". Psychiatry. 6 (5): 183–187. doi:10.1016/j.mppsy.2007.03.003.
↑  
Allgulander, C; Bandelow, B; Hollander, E; Montgomery, SA; Nutt, DJ; Okasha, A; Pollack, MH; Stein, DJ; Swinson, RP; World Council Of, Anxiety (2003). "WCA recommendations for the long-term treatment of generalized anxiety disorder". CNS spectrums. 8 (8 Suppl 1): 53–61. PMID 14767398.
↑  
Stewart, S.; Westra, H. (2002). "Introduction to the Special Issue on: Benzodiazepine Side-Effects: From the Bench to the Clinic". Current Pharmaceutical Design. 8 (1): 1–3. doi:10.2174/1381612023396708. PMID 11812246.
↑  
Bandelow, Borwin; Wedekind, Dirk; Leon, Teresa (2007). "Pregabalin for the treatment of generalized anxiety disorder: A novel pharmacologic intervention". Expert Review of Neurotherapeutics. 7 (7): 769–81. doi:10.1586/14737175.7.7.769. PMID 17610384.
↑  
Owen, R.T. (2007). "Pregabalin: Its efficacy, safety and tolerability profile in generalized anxiety". Drugs of Today. 43 (9): 601–10. doi:10.1358/dot.2007.43.9.1133188. PMID 17940637.
↑  Wensel, T. M.; Powe, K. W.; Cates, M. E. (2012). "Pregabalin for the Treatment of Generalized Anxiety Disorder". Annals of Pharmacotherapy. 46 (3): 424–9. doi:10.1345/aph.1Q405. PMID 22395254.
↑  Rif S. El-Mallakh; S. Nassir Ghaemi (2 April 2007). Bipolar Depression: A Comprehensive Guide. American Psychiatric Pub. p. 158. ISBN 978-1-58562-651-9.
↑  Stephen M. Stahl; Bret A. Moore (13 February 2013). Anxiety Disorders: A Guide for Integrating Psychopharmacology and Psychotherapy. Routledge. p. 65. ISBN 978-1-136-44588-0.
↑  Reynolds, D John; Coleman, Jamie; Aronson, Jeffrey (10 November 2011). Oxford Handbook of Practical Drug Therapy. Oxford University Press. p. 765. ISBN 978-0-19-956285-5.
↑  Moffitt, Terrie E.; Harrington, H; Caspi, A; Kim-Cohen, J; Goldberg, D; Gregory, AM; Poulton, R (2007). "Depression and Generalized Anxiety Disorder". Archives of General Psychiatry. 64 (6): 651–60. doi:10.1001/archpsyc.64.6.651. PMID 17548747.
↑  Wolitzky-Taylor, Kate B.; Castriotta, Natalie; Lenze, Eric J.; Stanley, Melinda A.; Craske, Michelle G. (2010). "Anxiety disorders in older adults: A comprehensive review". Depression and Anxiety. 27 (2): 190–211. doi:10.1002/da.20653. PMID 20099273.
1 2  Scott, EL (6 September 2011). "Anxiety Disorders With Comorbid Substance Abuse". Psychiatric Times. คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 12 December 2019. สืบค้นเมื่อ 1 July 2013.{{cite web}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Smith, Joshua P.; Book, Sarah W. (2010). "Comorbidity of generalized anxiety disorder and alcohol use disorders among individuals seeking outpatient substance abuse treatment". Addictive Behaviors. 35 (1): 42–5. doi:10.1016/j.addbeh.2009.07.002. PMC 2763929. PMID 19733441.
↑  Lee, S.; Wu, J.; Ma, Y. L.; Tsang, A.; Guo, W.-J.; Sung, J. (2009). "Irritable bowel syndrome is strongly associated with generalized anxiety disorder: A community study". Alimentary Pharmacology & Therapeutics. 30 (6): 643–651. doi:10.1111/j.1365-2036.2009.04074.x. PMID 19552631.
↑  http://web.a.ebscohost.com.une.idm.oclc.org/ehost/pdfviewer/pdfviewer?sid=250bfc45-6db0-46c5-9d2a-21828b2116ea%40sessionmgr4002&vid=4&hid=4112
↑  Stephen V. Faraone, PhD; Arun R. Kunwar, MD. "ADHD in Children With Comorbid Conditions: ADHD and Anxiety". Medscape. สืบค้นเมื่อ 2013-01-15.{{cite web}}:  CS1 maint: uses authors parameter (ลิงก์)
↑  Newman, Michelle; Przeworski, Amy; Fisher, Aaron; Borkovec, Thomas (2010). "Diagnostic Comorbidityin Adults With Generalized Anxiety Disorder: Impact of Comorbidity on Psychotherapy Outcome and Impact of Psychotherapy on Comorbidity Diagnoses". Behav Ther. 41: 59–72. doi:10.1016/j.beth.2008.12.005. PMC 2827339. PMID 20171328.
1 2  "Relating the burden of anxiety and depression to effectiveness of treatment" (PDF). World Health Organization. 2000.
1 2  Yates, William R. "Anxiety Disorders". eMedicine.
↑  Kessler, Ronald C.; Chiu, WT; Demler, O; Merikangas, KR; Walters, EE (2005). "Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication". Archives of General Psychiatry. 62 (6): 617–27. doi:10.1001/archpsyc.62.6.617. PMC 2847357. PMID 15939839.
↑  Grant, Bridget F.; Hasin, Deborah S.; Stinson, Frederick S.; Dawson, Deborah A.; June Ruan, W.; Goldstein, Risë B.; Smith, Sharon M.; Saha, Tulshi D.; Huang, Boji (2005). "Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: Results from the National Epidemiologic Survey on Alcohol and Related Conditions". Psychological Medicine. 35 (12): 1747–59. doi:10.1017/S0033291705006069. PMID 16202187.
↑  Albano, Anne Marie; Chorpita, Bruce F.; Barlow, David H. (2003). "Childhood Anxiety Disorders".  ใน Mash, Eric J.; Barkley, Russell A. (บ.ก.). Child Psychopathology (2nd ed.). New York: Guilford Press. pp. 279–329. ISBN 978-1-57230-609-7.
↑  Keeton, CP; Kolos, AC; Walkup, JT (2009). "Pediatric generalized anxiety disorder: epidemiology, diagnosis, and management". Paediatric Drugs. 11 (3): 171–83. doi:10.2165/00148581-200911030-00003. PMID 19445546. S2CID 39870253.
↑  Schacter, Daniel L.; Gilbert, Daniel T.; Wegner, Daniel M. (2011). "Generalized Anxiety Disorders". Psychology (2nd ed.). New York: Worth, Incorporated. pp. 559–560.
↑  Soto, José A.; Dawson-Andoh, Nana A.; Belue, Rhonda (March 2011). "The relationship between perceived discrimination and Generalized Anxiety Disorder among African Americans, Afro Caribbeans, and non-Hispanic Whites". Journal of Anxiety Disorders. 25 (2): 258–265. doi:10.1016/j.janxdis.2010.09.011. PMC 3053120. PMID 21041059.
↑  Neal, Angela M.; Turner, Samuel M. (May 1991). "Anxiety disorders research with African Americans: Current status". Psychological Bulletin. 109 (3): 400–410. doi:10.1037/0033-2909.109.3.400. PMID 2062979.
↑  "Socioeconomic correlates of generalized anxiety disorder and major depression in primary care: The GADIS II study (Generalized Anxiety and Depression Impact Survey II)". Depression and Anxiety. 26 June 2007. doi:10.1002/da.20306.
↑  Cameron, Alasdair (2004). Crash Course Psychiatry. Elsevier Ltd. ISBN 0-7234-3340-2.
↑  Shalev, I; Moffitt, Terrie Edith; Braithwaite, A W; Danese, A; Fleming, N I; Goldman-Mellor, S; Harrington, H L; Houts, R M; Israel, S; Poulton, R; Robertson, S P; Sugden, K; Williams, B; Caspi, A;  และคณะ (2014-01-14). "Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder" (PDF). Molecular Psychiatry. 19 (11): 1163–1170. doi:10.1038/mp.2013.183. PMC 4098012. PMID 24419039. คลังข้อมูลเก่าเก็บจากแหล่งเดิม (PDF)เมื่อ 23 April 2014. สืบค้นเมื่อ 21 April 2014.